These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8253163)

  • 1. Schistosoma mansoni: induction of protective immunity in rats using a recombinant fragment of a parasite surface antigen.
    Soisson LA; Strand M
    Exp Parasitol; 1993 Dec; 77(4):492-4. PubMed ID: 8253163
    [No Abstract]   [Full Text] [Related]  

  • 2. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
    El Ridi R; Tallima H
    Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in vaccine research against schistosomiasis in Brazil.
    Oliveira SC; Fonseca CT; Cardoso FC; Farias LP; Leite LC
    Acta Trop; 2008; 108(2-3):256-62. PubMed ID: 18577363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immunity in baboons vaccinated with a recombinant antigen or radiation-attenuated cercariae of Schistosoma mansoni is antibody-dependent.
    Soisson LA; Reid GD; Farah IO; Nyindo M; Strand M
    J Immunol; 1993 Nov; 151(9):4782-9. PubMed ID: 8409436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective antigens in experimental schistosomiasis.
    Capron A; Pierce R; Balloul JM; Grzych JM; Dissous C; Sondermeyer P; Lecocq JP
    Acta Trop Suppl; 1987 Jun; 12():63-9. PubMed ID: 2442987
    [No Abstract]   [Full Text] [Related]  

  • 6. Schistosoma spp.: progress toward a defined vaccine.
    James SL
    Exp Parasitol; 1987 Jun; 63(3):247-52. PubMed ID: 3108024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective monoclonal antibody against Schistosoma mansoni: antigen isolation, characterization, and suitability for active immunization.
    Hazdai RT; Levi-Schaffer F; Brenner V; Horowitz S; Eshhar Z; Arnon R
    J Immunol; 1985 Oct; 135(4):2772-9. PubMed ID: 4031500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination against Schistosoma mansoni with purified surface antigens.
    Smith MA; Clegg JA
    Science; 1985 Feb; 227(4686):535-8. PubMed ID: 3966161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schistosoma mansoni surface antigen defined by a rat monoclonal IgG2a.
    Dissous C; Grzych JM; Capron A
    J Immunol; 1982 Nov; 129(5):2232-4. PubMed ID: 7119443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schistosome membrane proteins as vaccines.
    Loukas A; Tran M; Pearson MS
    Int J Parasitol; 2007 Mar; 37(3-4):257-63. PubMed ID: 17222846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of surface antigens on adult Schistosoma mansoni and Schistosoma haematobium.
    Shah J; Ramasamy R; Kinoti GK
    East Afr Med J; 1985 Nov; 62(11):776-83. PubMed ID: 3830680
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of a recombinant Schistosoma mansoni 28 kDa antigen for vaccination of zebu calves against S. bovis.
    Aradaib IE; Osburn BI
    Vaccine; 1995 Jan; 13(1):130. PubMed ID: 7762269
    [No Abstract]   [Full Text] [Related]  

  • 13. Current status and future prospects for a vaccine against schistosomiasis.
    Lebens M; Sun JB; Czerkinsky C; Holmgren J
    Expert Rev Vaccines; 2004 Jun; 3(3):315-28. PubMed ID: 15176948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The responses to Schistosoma mansoni of infected mice and non-infected mice following parabiosis. I--Histological aspects.
    Fuks MA; Santa Rosa GL; Savino W; Goulart EG
    An Microbiol (Rio J); 1982; 27():129-38. PubMed ID: 6765355
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune response to Schistosoma mansoni calreticulin in schistosomiasis resistant individuals.
    El Naglaa G; Zada S; El Demellawy MA
    Egypt J Immunol; 2004; 11(2):37-45. PubMed ID: 16734116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The response to Schistosoma mansoni of infected mice and non-infected mice following parabiosis. II--Immunological aspects.
    Fuks MA; Coulart EG; Santa Rosa GL
    An Microbiol (Rio J); 1982; 27():147-58. PubMed ID: 6985406
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms of immune evasion in schistosomiasis.
    Pearce EJ; Sher A
    Contrib Microbiol Immunol; 1987; 8():219-32. PubMed ID: 3304833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological speciation of human schistosome infections by ELISA with a panel of three antigens.
    Turner P; Lalloo K; Bligh J; Armstrong M; Whitty CJ; Doenhoff MJ; Chiodini PL
    J Clin Pathol; 2004 Nov; 57(11):1193-6. PubMed ID: 15509682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schistosoma mansoni: vaccination with adult worm antigens.
    Tendler M; Pinto RM; Oliveira Lima A; Gebara G; Katz N
    Int J Parasitol; 1986 Aug; 16(4):347-52. PubMed ID: 3091519
    [No Abstract]   [Full Text] [Related]  

  • 20. Calpain is the target antigen of a Th1 clone that transfers protective immunity against Schistosoma mansoni.
    Jankovic D; Aslund L; Oswald IP; Caspar P; Champion C; Pearce E; Coligan JE; Strand M; Sher A; James SL
    J Immunol; 1996 Jul; 157(2):806-14. PubMed ID: 8752932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.